Marshall Wace’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.7M Buy
621,621
+532,128
+595% +$27M 0.02% 550
2026
Q1
$4.77M Buy
+89,493
New +$5.26M ﹤0.01% 1329
2025
Q4
Sell
-25,552
Closed -$1.54M 3184
2025
Q3
$1.54M Buy
25,552
+688
+3% +$42.1K ﹤0.01% 1738
2025
Q2
$1.56M Sell
24,864
-26,495
-52% -$1.59M ﹤0.01% 1673
2025
Q1
$3.09M Buy
+51,359
New +$3.19M ﹤0.01% 1275
2024
Q4
Sell
-6,929
Closed -$410K 2772
2024
Q3
$410K Sell
6,929
-7,967
-53% -$455K ﹤0.01% 1992
2024
Q2
$835K Sell
14,896
-334,539
-96% -$18.7M ﹤0.01% 1768
2024
Q1
$20.5M Buy
349,435
+20,801
+6% +$1.17M 0.03% 503
2023
Q4
$17.7M Buy
+328,634
New +$16.1M 0.03% 507
2023
Q3
Sell
-153,266
Closed -$8.65M 2430
2023
Q2
$8.65M Buy
153,266
+146,402
+2,133% +$8.06M 0.02% 800
2023
Q1
$371K Sell
6,864
-47,036
-87% -$2.5M ﹤0.01% 2222
2022
Q4
$2.83M Buy
+53,900
New +$2.74M 0.01% 1532
2022
Q3
Sell
-6,656
Closed -$336K 3545
2022
Q2
$336K Buy
+6,656
New +$363K ﹤0.01% 2980
2022
Q1
Sell
-23,522
Closed -$1.55M 3636
2021
Q4
$1.55M Sell
23,522
-56,043
-70% -$3.59M ﹤0.01% 2207
2021
Q3
$5M Sell
79,565
-46,273
-37% -$2.95M 0.02% 933
2021
Q2
$7.57M Buy
125,838
+87,228
+226% +$5.04M 0.03% 614
2021
Q1
$2.13M Buy
+38,610
New +$2.14M 0.01% 1299

Other funds holding IHI

Marshall Wace's IHI Position: Q2 2026 in Review

Marshall Wace increased its iShares US Medical Devices ETF (IHI) stake by 595% in Q2 2026, buying an estimated $27M and bringing the position to 621,621 shares worth $30.7M. The position accounts for 0.02% of the portfolio, ranked #550.

Marshall Wace first reported a position in IHI in Q1 2021 and has held it in 17 quarters since. 502 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Marshall Wace held 621,621 shares of iShares US Medical Devices ETF worth $30.7M as of Q2 2026.
  • Marshall Wace bought 532,128 iShares US Medical Devices ETF shares in Q2 2026, an estimated $27M.
  • iShares US Medical Devices ETF made up 0.02% of Marshall Wace's portfolio in Q2 2026, its #550 holding.
  • Marshall Wace first reported a position in iShares US Medical Devices ETF in Q1 2021 and has held it in 17 quarters since.
  • 502 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.